These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 23573522)
21. Management of anemia in advanced breast and lung cancer patients in daily practice: results of a French survey. Ray-Coquard I; Morère JF; Scotté F; Cals L; Antoine EC Adv Ther; 2012 Feb; 29(2):124-33. PubMed ID: 22314432 [TBL] [Abstract][Full Text] [Related]
22. Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience. Renwick W; Pettengell R; Green M BioDrugs; 2009; 23(3):175-86. PubMed ID: 19627169 [TBL] [Abstract][Full Text] [Related]
23. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology. Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166 [TBL] [Abstract][Full Text] [Related]
24. [Bone marrow suppression--including guidelines for the appropriate use of G-CSF]. Watanabe T Gan To Kagaku Ryoho; 2003 Jun; 30(6):755-9. PubMed ID: 12852340 [TBL] [Abstract][Full Text] [Related]
25. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma. Kushner BH; Heller G; Kramer K; Cheung NK Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054 [TBL] [Abstract][Full Text] [Related]
26. Haematopoietic growth factors as supportive therapy in HIV-infected patients. Hermans P AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801 [TBL] [Abstract][Full Text] [Related]
27. G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients. Krol J; Paepke S; Jacobs VR; Paepke D; Euler U; Kiechle M; Harbeck N Onkologie; 2006 Apr; 29(4):171-8. PubMed ID: 16601374 [TBL] [Abstract][Full Text] [Related]
28. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort. Yong K; Kairaitis L Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296 [TBL] [Abstract][Full Text] [Related]
29. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study. Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127 [TBL] [Abstract][Full Text] [Related]
31. A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment. Younossi ZM; Nader FH; Bai C; Sjogren R; Ong JP; Collantes R; Sjogren M; Farmer D; Ramsey L; Terra K; Gujral H; Gurung C; Srishord M; Fang Y J Viral Hepat; 2008 May; 15(5):370-8. PubMed ID: 18194172 [TBL] [Abstract][Full Text] [Related]
32. Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor. Nichols CR; Fox EP; Roth BJ; Williams SD; Loehrer PJ; Einhorn LH J Clin Oncol; 1994 Jun; 12(6):1245-50. PubMed ID: 7515413 [TBL] [Abstract][Full Text] [Related]
33. Guidelines for the use of erythropoietic growth factors in patients with chemotherapy-induced anemia. Rodgers GM Oncology (Williston Park); 2006 Jul; 20(8 Suppl 6):12-5. PubMed ID: 16925105 [TBL] [Abstract][Full Text] [Related]
34. Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy. Wauters I; Vansteenkiste J Expert Rev Anticancer Ther; 2012 Nov; 12(11):1383-90. PubMed ID: 23113603 [TBL] [Abstract][Full Text] [Related]
35. Impact of cancer supportive care pathways compliance on emergency department visits and hospitalizations. Kreys ED; Kim TY; Delgado A; Koeller JM J Oncol Pract; 2014 May; 10(3):168-73. PubMed ID: 24839275 [TBL] [Abstract][Full Text] [Related]
36. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated. Nowrousian MR; Dunst J; Vaupel P Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508 [TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation. Shord SS; Cuellar S J Am Pharm Assoc (2003); 2008; 48(4):487-93. PubMed ID: 18653424 [TBL] [Abstract][Full Text] [Related]
38. The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study. Mäenpää J; Varthalitis I; Erdkamp F; Trojan A; Krzemieniecki K; Lindman H; Bendall K; Vogl FD; Verma S Breast; 2016 Feb; 25():27-33. PubMed ID: 26801413 [TBL] [Abstract][Full Text] [Related]
39. [Primary and secondary prophylactic administration of granulocyte-colony stimulating factor(G-CSF)for febrile neutropenia]. Uchino K; Baba E Gan To Kagaku Ryoho; 2014 Jun; 41(6):691-3. PubMed ID: 25129081 [TBL] [Abstract][Full Text] [Related]
40. Neutropenia management with granulocyte colony-stimulating factors: from guidelines to nursing practice protocols. Dolan S; Crombez P; Munoz M Eur J Oncol Nurs; 2005; 9 Suppl 1():S14-23. PubMed ID: 16207534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]